Baseline clinical and angiographic characteristics
| PCB (n=28) | Taxus stent (n=29) | p | |
| Men | 22 (78.6%) | 22 (75.9%) | 0.81 |
| Age±SD (years) | 68±9 | 67±10 | 0.67 |
| Hypertension | 21 (75.0%) | 20 (70.8%) | 0.61 |
| Diabetes mellitus | 13 (37.9%) | 11 (46.4%) | 0.51 |
| Dyslipidemia | 17 (60.7%) | 13 (54.2%) | 0.23 |
| Previous revascularisation with CABG | 3 (10.7%) | 4 (13.8%) | 0.72 |
| Previous revascularisation with PCI | 3 (10.7%) | 4 (13.8%) | 0.72 |
| Previous myocardial infarction | 5 (17.9%) | 6 (20.7%) | 0.78 |
| Stable angina | 13 (46.4%) | 13 (44.8%) | 0.90 |
| Type B2/C lesions* | 17 (60.7%) | 20 (69.0%) | 0.51 |
| Bifurcation lesion | 6 (21.4%) | 7 (24.1%) | 0.81 |
| Lesion length±SD (mm) | 12.41±5.89 | 11.38±7.12 | 0.56 |
| Reference vessel diameter±SD (mm) | 2.45±0.28 | 2.36±0.25 | 0.20 |
| MLD±SD (mm) | 0.48±0.33 | 0.40±0.30 | 0.30 |
| Lesion stenosis±SD (% LD) | 86.0±12.1 | 89.14±10.6 | 0.31 |
↵* According to ACC/AHA classification, SG Ellis et al, Circulation 1990; 82(4):1193-1202.
CABG, coronary artery bypass intervention; LD, lumen diameter; MLD, minimal lumen diameter; PCB, paclitaxel-coated balloon; PCI, percutaneous coronary intervention.